BEATW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -164.2%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Heartbeam Inc. Warrant
Company profileHeartbeam Inc. Warrant (BEATW) offers a compelling investment opportunity tied to Heartbeam Inc., an innovative healthcare technology company dedicated to revolutionizing cardiac diagnostics through artificial intelligence and digital health solutions. The company's advanced platform enhances diagnostic accuracy for myocardial infarctions, promoting timely medical interventions that can drastically improve patient outcomes. In a landscape where demand for remote monitoring and telehealth services is surging, Heartbeam stands poised to leverage significant market growth, positioning BEATW as a…
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NONE
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer